eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | small cell carcinoma |
| Comorbidity | C0027947|neutropenia |
| Sentences | 2 |
| PubMedID- 20644495 | Background: previous studies investigating the effect of increased dose intensity and chemotherapy-induced neutropenia in patients with advanced non-small cell lung cancer (nsclc) have not consistently shown significant survival benefits. |
| PubMedID- 23489558 | Clinicians should be aware that gefitinib-induced neutropenia in patients with non-small cell lung cancer can be treated successful by switching to erlotinib. |
Page: 1